BioTech Medics Inc (BMCS)

[fatnhappy2]

BioTech Medics CEO Challenges Ebola Cannot Be Spread
by Coughing or Sneezing


October 11, 2014, Dallas-Ft Worth Metroplex, TX – Keith A. Houser, CEO of BioTech Medics, Inc., (Pinksheets symbol: BMCS) is challenging any licensed Medical Practitioner and/or US Government Official or spokesperson who alleges that it is “impossible to become infected by a cough and/or sneeze of a person who has active Ebola Virus”. Mr. Houser’s challenge is based upon extensive scientific studies of Ebola, other viruses and influenza viruses in support if his challenge.
According to Livescience.com*: “The average human cough could fill about three-quarters of a two-liter soda bottle with air — air that shoots out of the lungs in a jet several feet long (CDC quote says “six feet”). Coughs also force out thousands of tiny droplets of saliva.
About 3,000 droplets are expelled in a single cough, and some of them fly out of the mouth at speeds of up to 50 miles per hour.”
According to the CDC: “These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.”
Additionally, Sneezing is even worse.
“Sneezing starts at the back of the throat and produces even more droplets — as many as 40,000 — some of which rocket out at speeds greater than 200 miles per hour. The vast majority of the droplets are less than 100 microns across — the width of a human hair. Many of them are so tiny that they cannot be seen with the naked eye. What happens to these droplets depends on their size," said fluid dynamicist Bakhtier Farouk of Drexel University in Philadelphia. He is working on software that models how microscopic droplets move around a room.
Most of the larger, heavier drops fall quickly to the floor under the influence of gravity. The smaller and lighter particles (those that are five microns or less across) are less affected by gravity and can stay airborne almost indefinitely as they are caught up in and dispersed by the room's airflow.
Movements in a room can cause the heavier droplets to become airborne again after they have fallen to the ground or another surface. Making a sick person’s bed can kick up viruses on the covers. Opening a door can dramatically alter the airflow in the room and pull up viruses on the floor. Even walking through a room can spread droplets in a person's wake.
If a person is sick, the droplets in a single cough may contain as many as two hundred million individual virus particles. The number varies dramatically and changes over the course of an infection as the immune system clears out the virus.
Generally, a sick person is most infectious as soon as the first symptoms appear and less infectious as his or her immune system clears the virus.
Once airborne, viruses in these tiny droplets can survive for hours. Even if the droplets hit a surface, the viruses can survive and still spread disease if the droplets become airborne later. When a droplet lands on paper, its virus particles can survive for hours. On steel or plastic they can survive for days.
“Once they are breathed in through the nose or mouth, the droplets settle onto cells at the back of the throat, where the virus attempts to enter these cells and begin replicating. This may or may not cause an infection. The body's natural defenses are designed to eliminate infections, and whether someone will fall ill depends on how much virus is breathed in and whether the person's immune system has encountered that virus previously”, said Julian Tang, a clinical virologist in Singapore.
The body tries to deal with the infection when a person becomes ill by bringing up mucus to help clear the mucus. Some mucus is swallowed, thereby carrying the virus down to be destroyed by stomach acid. Some viruses in the throat, though, will be expelled when we cough, and this coughing expels the mucus (and new virus) out of the body, thus beginning the whole process anew.
Dr. C.J. Peters, who battled a 1989 outbreak of the virus among research monkeys housed in Virginia and who later led the CDC’s far-reaching study of Ebola’s transmissibility in humans, said he would not rule out the possibility that it (Ebola) spreads through the air in tight quarters.

“We just don’t have the data to exclude it,” said Peters, who continues to research viral diseases at the University of Texas in Galveston.

Dr. Philip K. Russell, a virologist who oversaw Ebola research while heading the U.S. Army’s Medical Research and Development Command, and who later led the government’s massive stockpiling of smallpox vaccine after the Sept. 11 terrorist attacks, also said much was still to be learned.

“Being dogmatic is, I think, ill-advised, because there are too many unknowns here.”

“I see the reasons to dampen down public fears,” Russell said. “But scientifically, we’re in the middle of the first experiment of multiple, serial passages of Ebola virus in man…. God knows what this virus is going to look like. I don’t.”

In late 1989, virus researcher Charles L. Bailey supervised the government’s response to an outbreak of Ebola among several dozen rhesus monkeys housed for research in Reston, Va., a suburb of Washington.

What Bailey learned from the episode informs his suspicion that the current strain of Ebola afflicting humans might be spread through tiny liquid droplets propelled into the air by coughing or sneezing.

“We know for a fact that the virus occurs in sputum and no one has ever done a study [disproving that] coughing or sneezing is a viable means of transmitting”, he said. Unqualified assurances that Ebola is not spread through the air, Bailey said, are “misleading.”

Peters, whose CDC team studied cases from 27 households that emerged during a 1995 Ebola outbreak in Democratic Republic of Congo, said that while most could be attributed to contact with infected late-stage patients or their bodily fluids, “some” infections may have occurred via “aerosol transmission.”
Finally, Mr. Houser stated to the general public: “Don’t be fooled in using alcohol gel hand sanitizers with 62% or less alcohol active ingredient. Alcohol gels have not been proven to kill ‘viruses’ only ‘germs’. Ebola is NOT a germ. Only FDA Class I, ‘persistent’hand sanitizers have been shown to inhibit viruses according to laboratory tests. I do not know of any testing of Class I persistent hand sanitizers that have demonstrated they kill the Ebola virus”.
Sources:
• http://www.livescience.com/3686-gross-science-cough-sneeze.html
• http://www.cdc.gov/flu/about/disease/spread.htm
• http://www.zerohedge.com/news/2014-10-07/cdc-forced-admit-ebola-might-be-spread-through-coughing-and-sneezing
• Also, quotes from the Los Angeles Times
Contact:
Keith Houser, CEO
BioTech Medics Inc.
Email: [e-mail]
© BioTech Medics Inc., All rights reserved.